| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.085 | 0.1 |